|By Marketwired .||
|July 7, 2014 01:30 PM EDT||
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/07/14 -- Geodex Minerals Ltd. (TSX VENTURE: GXM)(FRANKFURT: G2W), ("Geodex") is pleased to announce that it has appointed Dr. Michael Hirschberger to its Advisory Board.
Dr. Hirschberger is a Principal and CEO of Strategic Min-Metals, AG, Vienna, a niche company focused on the exploitation of Chromite in selected countries. He previously organized and operated Global Min-Metal Holdings, SA, an exploration company, developing manganese ore principally in Panama. He also served recently as an independent director of a TSX-listed exploration company with Antimony interests.
Dr. Hirschberger held various positions with the Wall Street firms of White, Weld & Company, Northern Trust, Societe Generale S.A. in New York and his own firm, Healthcare Capital Group, based in Geneva, Switzerland. He served as a senior analyst; Managing Director in Corporate Finance, and a venture capitalist focused on early stage medical device and specialty pharmaceutical companies, respectively.
Geodex is a mineral resource company focused on critical metal projects and particularly in the Maritime Provinces of Canada. Geodex has operated for a decade in New Brunswick where it has had a number of discovery and development successes including Sisson and Mount Pleasant West.
ON BEHALF OF THE BOARD OF DIRECTORS
GEODEX MINERALS LTD.
Christopher Ecclestone, President & CEO
Tel: (44) 795 08 53 621
Forward Looking Statement
Certain information regarding the Company contained in this press release may constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements may include estimates, plans, opinions, forecasts, projections or other statements that are not statements of fact. Although the Company believes that expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. The Company cautions that actual performance will be affected by a number of factors, many of which are beyond the Company's control, and that future events and results may vary substantially from what the Company currently foresees.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Feb. 20, 2017 07:00 PM EST Reads: 8,208
Feb. 20, 2017 06:15 PM EST Reads: 789
Feb. 20, 2017 06:15 PM EST Reads: 4,300
Feb. 20, 2017 06:15 PM EST Reads: 981
Feb. 20, 2017 05:45 PM EST Reads: 454
Feb. 20, 2017 05:30 PM EST Reads: 3,892
Feb. 20, 2017 05:30 PM EST Reads: 2,227
Feb. 20, 2017 05:15 PM EST Reads: 951
Feb. 20, 2017 02:45 PM EST Reads: 441
Feb. 20, 2017 02:15 PM EST Reads: 1,091
Feb. 20, 2017 01:15 PM EST Reads: 412
Feb. 20, 2017 01:00 PM EST Reads: 10,050
Feb. 20, 2017 01:00 PM EST Reads: 847
Feb. 20, 2017 01:00 PM EST Reads: 5,852
Feb. 20, 2017 01:00 PM EST Reads: 1,198